Abiopharma

Fennec Pharmaceuticals Announces Private Offering of Common Shares in Canada

Fennec Pharmaceuticals Announces Pricing of Offering of Common Shares

Indivior Notification

Reviva to Present Anti-Inflammatory Impacts of Brilaroxazine at Neuroscience 2025

Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Fibrosis

Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs

SC 13G/A (Amended Statement of Ownership) SEC Filing

DexCom, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – DXCM

UTHR: Notification

“LEQEMBI®” (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Approved in the United Kingdom